BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, November 29, 2024
See today's BioWorld
Home
» Other news to note for April 22, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for April 22, 2020
April 22, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ablexis, Alkermes, Alpha Cognition, Anticancer, Applied Biomath, Asklepios, Avacta, Bayer Bonus Biogroup, Brainvectis, Caladrius, Cellphire, Cocrystal Pharma, Cormedix, Cyclica, Emergex Vaccines, Envisagenics, Etherna, Evotec, Frame, Gilead, Hoth, Immunic, Johnson & Johnson, Kalos, Kite, Linical, Northern Biologics, Nuritas, Oncology Venture, Onko-innate, Pharnext, Q Biomed, Sanofi, Som, Targovax, Valo, Wize, Wuxi, Zylö Therapeutics.
BioWorld
Briefs
Other news to note
Coronavirus